Find trials
Search tips

A Study of Breast Imaging with F-18 Fluoroestradiol in Patients with Newly Diagnosed ER+ Breast Cancer

Overview

About this study

The purpose of this study is to obtain additional high resolution images of your breast cancer using a Positron Emission Mammography (PEM) system. This system only allows us to image the breast, but provides higher quality and better resolution than those images we obtain with the PET/CT scanner.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Female subjects will be eligible if they:

  1. Enroll in the ECOG EAI142 trial.
  2. Provide signed written informed consent

Exclusion Criteria:

Subjects will be excluded if they:

  1. Have undergone lumpectomy or mastectomy for primary breast tumor
  2. Are unable to lie prone on a table for 10 minutes
  3. Exceed the weight limit on the PEM imaging table (135 kg.)

 

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20362903

Mayo Clinic Footer